Cases & Deals

Undisclosed investor completes $13 million exchange offer of Convertible Notes by Oscient Pharmaceuticals

Clients Undisclosed investor

Jones Day represented an undisclosed investor in connection with the exchange of approximately $13 million of 5% Convertible Notes due 2009 issued by Oscient Pharmaceuticals Corporation, a biopharmaceutical company, reducing the conversion price from $53.13 to $1.10 per share, which was accepted by holders of approximately 99% of the 2009 notes. The exchanged notes include a provision for the optional exchange into the Company's 12.50% Convertible Guaranteed Senior Notes due 2011 at the election of the noteholder.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.